Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
28,961,082
-
Total 13F shares
-
2,040,704
-
Share change
-
+1,609,188
-
Total reported value
-
$2,224,369
-
Price per share
-
$1.09
-
Number of holders
-
15
-
Value change
-
+$1,747,783
-
Number of buys
-
7
-
Number of sells
-
6
Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q3 2024
As of 30 Sep 2024,
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,040,704 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, New Leaf Venture Partners, L.L.C., Apollon Financial, LLC, Alpine Global Management, LLC, XTX Topco Ltd, TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Activest Wealth Management, and WELLS FARGO & COMPANY/MN.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.